0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Monkeypox Virus Monoclonal Antibody Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-39B18717
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Monkeypox Virus Monoclonal Antibody Market Research Report 2025
BUY CHAPTERS

Global Monkeypox Virus Monoclonal Antibody Market Research Report 2026

Code: QYRE-Auto-39B18717
Report
2026-01-21
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Monkeypox Virus Monoclonal Antibody Market Size

The global Monkeypox Virus Monoclonal Antibody market was valued at US$ 1491 million in 2025 and is anticipated to reach US$ 2738 million by 2032, at a CAGR of 9.2% from 2026 to 2032.

Monkeypox Virus Monoclonal Antibody Market

Monkeypox Virus Monoclonal Antibody Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Monkeypox Virus Monoclonal Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Monkeypox virus monoclonal antibodies are highly homogeneous antibodies produced by a single B cell clone and target only a specific antigenic epitope of monkeypox virus.
The North American market for Monkeypox Virus Monoclonal Antibody is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Monkeypox Virus Monoclonal Antibody is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Monkeypox Virus Monoclonal Antibody include ProteoGenix, ACROBiosystems, Creative Diagnostics, Novus Biologicals, LLC, Merck Group, Absolute Antibody, Creative Biolabs, Sanyoubio, Cnpair, Vazyme, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Monkeypox Virus Monoclonal Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Monkeypox Virus Monoclonal Antibody. The Monkeypox Virus Monoclonal Antibody market size, estimates, and forecasts are provided in terms of sales volume (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Monkeypox Virus Monoclonal Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Monkeypox Virus Monoclonal Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Monkeypox Virus Monoclonal Antibody Market Report

Report Metric Details
Report Name Monkeypox Virus Monoclonal Antibody Market
Accounted market size in 2025 US$ 1491 million
Forecasted market size in 2032 US$ 2738 million
CAGR 9.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Purity>90%
  • Purity>95%
  • Others
by Application
  • Diagnostic Laboratories
  • Research and Academic Laboratories
  • Pharmaceutical and Biotechnology Companies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ProteoGenix, ACROBiosystems, Creative Diagnostics, Novus Biologicals, LLC, Merck Group, Absolute Antibody, Creative Biolabs, Sanyoubio, Cnpair, Vazyme, Sinobiological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Monkeypox Virus Monoclonal Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Monkeypox Virus Monoclonal Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Monkeypox Virus Monoclonal Antibody Market growing?

Ans: The Monkeypox Virus Monoclonal Antibody Market witnessing a CAGR of 9.2% during the forecast period 2026-2032.

What is the Monkeypox Virus Monoclonal Antibody Market size in 2032?

Ans: The Monkeypox Virus Monoclonal Antibody Market size in 2032 will be US$ 2738 million.

Who are the main players in the Monkeypox Virus Monoclonal Antibody Market report?

Ans: The main players in the Monkeypox Virus Monoclonal Antibody Market are ProteoGenix, ACROBiosystems, Creative Diagnostics, Novus Biologicals, LLC, Merck Group, Absolute Antibody, Creative Biolabs, Sanyoubio, Cnpair, Vazyme, Sinobiological

What are the Application segmentation covered in the Monkeypox Virus Monoclonal Antibody Market report?

Ans: The Applications covered in the Monkeypox Virus Monoclonal Antibody Market report are Diagnostic Laboratories, Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies

What are the Type segmentation covered in the Monkeypox Virus Monoclonal Antibody Market report?

Ans: The Types covered in the Monkeypox Virus Monoclonal Antibody Market report are Purity>90%, Purity>95%, Others

1 Monkeypox Virus Monoclonal Antibody Market Overview
1.1 Product Definition
1.2 Monkeypox Virus Monoclonal Antibody by Type
1.2.1 Global Monkeypox Virus Monoclonal Antibody Market Value by Type: 2025 vs 2032
1.2.2 Purity>90%
1.2.3 Purity>95%
1.2.4 Others
1.3 Monkeypox Virus Monoclonal Antibody by Application
1.3.1 Global Monkeypox Virus Monoclonal Antibody Market Value by Application: 2025 vs 2032
1.3.2 Diagnostic Laboratories
1.3.3 Research and Academic Laboratories
1.3.4 Pharmaceutical and Biotechnology Companies
1.4 Global Monkeypox Virus Monoclonal Antibody Market Size Estimates and Forecasts
1.4.1 Global Monkeypox Virus Monoclonal Antibody Revenue 2021–2032
1.4.2 Global Monkeypox Virus Monoclonal Antibody Sales 2021–2032
1.4.3 Global Monkeypox Virus Monoclonal Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Monkeypox Virus Monoclonal Antibody Market Competition by Manufacturers
2.1 Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Monkeypox Virus Monoclonal Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Monkeypox Virus Monoclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Date of Entry into the Industry
2.8 Global Monkeypox Virus Monoclonal Antibody Market Competitive Situation and Trends
2.8.1 Global Monkeypox Virus Monoclonal Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Monkeypox Virus Monoclonal Antibody Players Market Share by Revenue
2.8.3 Global Monkeypox Virus Monoclonal Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Monkeypox Virus Monoclonal Antibody Market Scenario by Region
3.1 Global Monkeypox Virus Monoclonal Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Monkeypox Virus Monoclonal Antibody Sales by Region: 2021–2032
3.2.1 Global Monkeypox Virus Monoclonal Antibody Sales by Region: 2021–2026
3.2.2 Global Monkeypox Virus Monoclonal Antibody Sales by Region: 2027–2032
3.3 Global Monkeypox Virus Monoclonal Antibody Revenue by Region: 2021–2032
3.3.1 Global Monkeypox Virus Monoclonal Antibody Revenue by Region: 2021–2026
3.3.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Region: 2027–2032
3.4 North America Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Country
3.4.1 North America Monkeypox Virus Monoclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Monkeypox Virus Monoclonal Antibody Sales by Country (2021–2032)
3.4.3 North America Monkeypox Virus Monoclonal Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Country
3.5.1 Europe Monkeypox Virus Monoclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Monkeypox Virus Monoclonal Antibody Sales by Country (2021–2032)
3.5.3 Europe Monkeypox Virus Monoclonal Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Monkeypox Virus Monoclonal Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Monkeypox Virus Monoclonal Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Country
3.7.1 Latin America Monkeypox Virus Monoclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Monkeypox Virus Monoclonal Antibody Sales by Country (2021–2032)
3.7.3 Latin America Monkeypox Virus Monoclonal Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Monkeypox Virus Monoclonal Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Monkeypox Virus Monoclonal Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Monkeypox Virus Monoclonal Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Monkeypox Virus Monoclonal Antibody Sales by Type (2021–2032)
4.1.1 Global Monkeypox Virus Monoclonal Antibody Sales by Type (2021–2026)
4.1.2 Global Monkeypox Virus Monoclonal Antibody Sales by Type (2027–2032)
4.1.3 Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Type (2021–2032)
4.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Type (2021–2032)
4.2.1 Global Monkeypox Virus Monoclonal Antibody Revenue by Type (2021–2026)
4.2.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Type (2027–2032)
4.2.3 Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Monkeypox Virus Monoclonal Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Monkeypox Virus Monoclonal Antibody Sales by Application (2021–2032)
5.1.1 Global Monkeypox Virus Monoclonal Antibody Sales by Application (2021–2026)
5.1.2 Global Monkeypox Virus Monoclonal Antibody Sales by Application (2027–2032)
5.1.3 Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Application (2021–2032)
5.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Application (2021–2032)
5.2.1 Global Monkeypox Virus Monoclonal Antibody Revenue by Application (2021–2026)
5.2.2 Global Monkeypox Virus Monoclonal Antibody Revenue by Application (2027–2032)
5.2.3 Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Monkeypox Virus Monoclonal Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 ProteoGenix
6.1.1 ProteoGenix Company Information
6.1.2 ProteoGenix Description and Business Overview
6.1.3 ProteoGenix Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 ProteoGenix Monkeypox Virus Monoclonal Antibody Product Portfolio
6.1.5 ProteoGenix Recent Developments/Updates
6.2 ACROBiosystems
6.2.1 ACROBiosystems Company Information
6.2.2 ACROBiosystems Description and Business Overview
6.2.3 ACROBiosystems Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 ACROBiosystems Monkeypox Virus Monoclonal Antibody Product Portfolio
6.2.5 ACROBiosystems Recent Developments/Updates
6.3 Creative Diagnostics
6.3.1 Creative Diagnostics Company Information
6.3.2 Creative Diagnostics Description and Business Overview
6.3.3 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Product Portfolio
6.3.5 Creative Diagnostics Recent Developments/Updates
6.4 Novus Biologicals, LLC
6.4.1 Novus Biologicals, LLC Company Information
6.4.2 Novus Biologicals, LLC Description and Business Overview
6.4.3 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Product Portfolio
6.4.5 Novus Biologicals, LLC Recent Developments/Updates
6.5 Merck Group
6.5.1 Merck Group Company Information
6.5.2 Merck Group Description and Business Overview
6.5.3 Merck Group Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Merck Group Monkeypox Virus Monoclonal Antibody Product Portfolio
6.5.5 Merck Group Recent Developments/Updates
6.6 Absolute Antibody
6.6.1 Absolute Antibody Company Information
6.6.2 Absolute Antibody Description and Business Overview
6.6.3 Absolute Antibody Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Absolute Antibody Monkeypox Virus Monoclonal Antibody Product Portfolio
6.6.5 Absolute Antibody Recent Developments/Updates
6.7 Creative Biolabs
6.7.1 Creative Biolabs Company Information
6.7.2 Creative Biolabs Description and Business Overview
6.7.3 Creative Biolabs Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Creative Biolabs Monkeypox Virus Monoclonal Antibody Product Portfolio
6.7.5 Creative Biolabs Recent Developments/Updates
6.8 Sanyoubio
6.8.1 Sanyoubio Company Information
6.8.2 Sanyoubio Description and Business Overview
6.8.3 Sanyoubio Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sanyoubio Monkeypox Virus Monoclonal Antibody Product Portfolio
6.8.5 Sanyoubio Recent Developments/Updates
6.9 Cnpair
6.9.1 Cnpair Company Information
6.9.2 Cnpair Description and Business Overview
6.9.3 Cnpair Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Cnpair Monkeypox Virus Monoclonal Antibody Product Portfolio
6.9.5 Cnpair Recent Developments/Updates
6.10 Vazyme
6.10.1 Vazyme Company Information
6.10.2 Vazyme Description and Business Overview
6.10.3 Vazyme Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Vazyme Monkeypox Virus Monoclonal Antibody Product Portfolio
6.10.5 Vazyme Recent Developments/Updates
6.11 Sinobiological
6.11.1 Sinobiological Company Information
6.11.2 Sinobiological Description and Business Overview
6.11.3 Sinobiological Monkeypox Virus Monoclonal Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sinobiological Monkeypox Virus Monoclonal Antibody Product Portfolio
6.11.5 Sinobiological Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monkeypox Virus Monoclonal Antibody Industry Chain Analysis
7.2 Monkeypox Virus Monoclonal Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monkeypox Virus Monoclonal Antibody Production Mode & Process Analysis
7.4 Monkeypox Virus Monoclonal Antibody Sales and Marketing
7.4.1 Monkeypox Virus Monoclonal Antibody Sales Channels
7.4.2 Monkeypox Virus Monoclonal Antibody Distributors
7.5 Monkeypox Virus Monoclonal Antibody Customer Analysis
8 Monkeypox Virus Monoclonal Antibody Market Dynamics
8.1 Monkeypox Virus Monoclonal Antibody Industry Trends
8.2 Monkeypox Virus Monoclonal Antibody Market Drivers
8.3 Monkeypox Virus Monoclonal Antibody Market Challenges
8.4 Monkeypox Virus Monoclonal Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Monkeypox Virus Monoclonal Antibody Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Monkeypox Virus Monoclonal Antibody Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Monkeypox Virus Monoclonal Antibody Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Monkeypox Virus Monoclonal Antibody Sales (L) of Key Manufacturers (2021–2026)
 Table 5. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Monkeypox Virus Monoclonal Antibody Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Monkeypox Virus Monoclonal Antibody Average Price (US$/L) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Monkeypox Virus Monoclonal Antibody, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Product Types and Applications
 Table 12. Global Key Manufacturers of Monkeypox Virus Monoclonal Antibody, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Monkeypox Virus Monoclonal Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Monkeypox Virus Monoclonal Antibody Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Monkeypox Virus Monoclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Monkeypox Virus Monoclonal Antibody Sales by Region (L), 2021–2026
 Table 18. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Region (2021–2026)
 Table 19. Global Monkeypox Virus Monoclonal Antibody Sales by Region (L), 2027–2032
 Table 20. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Region (2027–2032)
 Table 21. Global Monkeypox Virus Monoclonal Antibody Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Region (2021–2026)
 Table 23. Global Monkeypox Virus Monoclonal Antibody Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Region (2027–2032)
 Table 25. North America Monkeypox Virus Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Monkeypox Virus Monoclonal Antibody Sales by Country (L), 2021–2026
 Table 27. North America Monkeypox Virus Monoclonal Antibody Sales by Country (L), 2027–2032
 Table 28. North America Monkeypox Virus Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Monkeypox Virus Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Monkeypox Virus Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Monkeypox Virus Monoclonal Antibody Sales by Country (L), 2021–2026
 Table 32. Europe Monkeypox Virus Monoclonal Antibody Sales by Country (L), 2027–2032
 Table 33. Europe Monkeypox Virus Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Monkeypox Virus Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Monkeypox Virus Monoclonal Antibody Sales by Region (L), 2021–2026
 Table 37. Asia Pacific Monkeypox Virus Monoclonal Antibody Sales by Region (L), 2027–2032
 Table 38. Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Monkeypox Virus Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Monkeypox Virus Monoclonal Antibody Sales by Country (L), 2021–2026
 Table 42. Latin America Monkeypox Virus Monoclonal Antibody Sales by Country (L), 2027–2032
 Table 43. Latin America Monkeypox Virus Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Monkeypox Virus Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Monkeypox Virus Monoclonal Antibody Sales by Country (L), 2021–2026
 Table 47. Middle East and Africa Monkeypox Virus Monoclonal Antibody Sales by Country (L), 2027–2032
 Table 48. Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Monkeypox Virus Monoclonal Antibody Sales (L) by Type (2021–2026)
 Table 51. Global Monkeypox Virus Monoclonal Antibody Sales (L) by Type (2027–2032)
 Table 52. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Type (2021–2026)
 Table 53. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Type (2027–2032)
 Table 54. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Type (2021–2026)
 Table 57. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Type (2027–2032)
 Table 58. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Type (2021–2026)
 Table 59. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Type (2027–2032)
 Table 60. Global Monkeypox Virus Monoclonal Antibody Sales (L) by Application (2021–2026)
 Table 61. Global Monkeypox Virus Monoclonal Antibody Sales (L) by Application (2027–2032)
 Table 62. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Application (2021–2026)
 Table 63. Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Application (2027–2032)
 Table 64. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Monkeypox Virus Monoclonal Antibody Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Application (2021–2026)
 Table 67. Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Application (2027–2032)
 Table 68. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Application (2021–2026)
 Table 69. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Application (2027–2032)
 Table 70. ProteoGenix Company Information
 Table 71. ProteoGenix Description and Business Overview
 Table 72. ProteoGenix Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 73. ProteoGenix Monkeypox Virus Monoclonal Antibody Product
 Table 74. ProteoGenix Recent Developments/Updates
 Table 75. ACROBiosystems Company Information
 Table 76. ACROBiosystems Description and Business Overview
 Table 77. ACROBiosystems Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 78. ACROBiosystems Monkeypox Virus Monoclonal Antibody Product
 Table 79. ACROBiosystems Recent Developments/Updates
 Table 80. Creative Diagnostics Company Information
 Table 81. Creative Diagnostics Description and Business Overview
 Table 82. Creative Diagnostics Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 83. Creative Diagnostics Monkeypox Virus Monoclonal Antibody Product
 Table 84. Creative Diagnostics Recent Developments/Updates
 Table 85. Novus Biologicals, LLC Company Information
 Table 86. Novus Biologicals, LLC Description and Business Overview
 Table 87. Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 88. Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Product
 Table 89. Novus Biologicals, LLC Recent Developments/Updates
 Table 90. Merck Group Company Information
 Table 91. Merck Group Description and Business Overview
 Table 92. Merck Group Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 93. Merck Group Monkeypox Virus Monoclonal Antibody Product
 Table 94. Merck Group Recent Developments/Updates
 Table 95. Absolute Antibody Company Information
 Table 96. Absolute Antibody Description and Business Overview
 Table 97. Absolute Antibody Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 98. Absolute Antibody Monkeypox Virus Monoclonal Antibody Product
 Table 99. Absolute Antibody Recent Developments/Updates
 Table 100. Creative Biolabs Company Information
 Table 101. Creative Biolabs Description and Business Overview
 Table 102. Creative Biolabs Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 103. Creative Biolabs Monkeypox Virus Monoclonal Antibody Product
 Table 104. Creative Biolabs Recent Developments/Updates
 Table 105. Sanyoubio Company Information
 Table 106. Sanyoubio Description and Business Overview
 Table 107. Sanyoubio Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 108. Sanyoubio Monkeypox Virus Monoclonal Antibody Product
 Table 109. Sanyoubio Recent Developments/Updates
 Table 110. Cnpair Company Information
 Table 111. Cnpair Description and Business Overview
 Table 112. Cnpair Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 113. Cnpair Monkeypox Virus Monoclonal Antibody Product
 Table 114. Cnpair Recent Developments/Updates
 Table 115. Vazyme Company Information
 Table 116. Vazyme Description and Business Overview
 Table 117. Vazyme Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 118. Vazyme Monkeypox Virus Monoclonal Antibody Product
 Table 119. Vazyme Recent Developments/Updates
 Table 120. Sinobiological Company Information
 Table 121. Sinobiological Description and Business Overview
 Table 122. Sinobiological Monkeypox Virus Monoclonal Antibody Sales (L), Revenue (US$ Million), Price (US$/L), and Gross Margin (2021–2026)
 Table 123. Sinobiological Monkeypox Virus Monoclonal Antibody Product
 Table 124. Sinobiological Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Monkeypox Virus Monoclonal Antibody Distributors List
 Table 128. Monkeypox Virus Monoclonal Antibody Customers List
 Table 129. Monkeypox Virus Monoclonal Antibody Market Trends
 Table 130. Monkeypox Virus Monoclonal Antibody Market Drivers
 Table 131. Monkeypox Virus Monoclonal Antibody Market Challenges
 Table 132. Monkeypox Virus Monoclonal Antibody Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Monkeypox Virus Monoclonal Antibody
 Figure 2. Global Monkeypox Virus Monoclonal Antibody Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Monkeypox Virus Monoclonal Antibody Market Share by Type: 2025 & 2032
 Figure 4. Purity>90% Product Picture
 Figure 5. Purity>95% Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Monkeypox Virus Monoclonal Antibody Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Monkeypox Virus Monoclonal Antibody Market Share by Application: 2025 & 2032
 Figure 9. Diagnostic Laboratories
 Figure 10. Research and Academic Laboratories
 Figure 11. Pharmaceutical and Biotechnology Companies
 Figure 12. Global Monkeypox Virus Monoclonal Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Monkeypox Virus Monoclonal Antibody Market Size (US$ Million), 2021–2032
 Figure 14. Global Monkeypox Virus Monoclonal Antibody Sales (L), 2021–2032
 Figure 15. Global Monkeypox Virus Monoclonal Antibody Average Price (US$/L), 2021–2032
 Figure 16. Monkeypox Virus Monoclonal Antibody Report Years Considered
 Figure 17. Monkeypox Virus Monoclonal Antibody Sales Share by Manufacturers in 2025
 Figure 18. Global Monkeypox Virus Monoclonal Antibody Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Monkeypox Virus Monoclonal Antibody Players: Market Share by Revenue in Monkeypox Virus Monoclonal Antibody in 2025
 Figure 20. Monkeypox Virus Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Monkeypox Virus Monoclonal Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Monkeypox Virus Monoclonal Antibody Sales Market Share by Country (2021–2032)
 Figure 23. North America Monkeypox Virus Monoclonal Antibody Revenue Market Share by Country (2021–2032)
 Figure 24. United States Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Monkeypox Virus Monoclonal Antibody Sales Market Share by Country (2021–2032)
 Figure 27. Europe Monkeypox Virus Monoclonal Antibody Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Monkeypox Virus Monoclonal Antibody Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Monkeypox Virus Monoclonal Antibody Revenue Market Share by Region (2021–2032)
 Figure 35. China Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Monkeypox Virus Monoclonal Antibody Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Monkeypox Virus Monoclonal Antibody Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Monkeypox Virus Monoclonal Antibody Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Monkeypox Virus Monoclonal Antibody Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Monkeypox Virus Monoclonal Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Monkeypox Virus Monoclonal Antibody by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Monkeypox Virus Monoclonal Antibody by Type (2021–2032)
 Figure 55. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Monkeypox Virus Monoclonal Antibody by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Monkeypox Virus Monoclonal Antibody by Application (2021–2032)
 Figure 58. Global Monkeypox Virus Monoclonal Antibody Price (US$/L) by Application (2021–2032)
 Figure 59. Monkeypox Virus Monoclonal Antibody Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS